The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Just Published

JCP
Risk of Alzheimer’s Disease and Vascular Dementia in Patients With Peripheral Vestibular Disorders
Original Research

June 2, 2025

The authors found that peripheral vestibular disorders are a risk factor for dementia, regardless of psychiatric comorbidities.
, , , et al
JCP
Idiopathic Hypersomnia: Recognition and Management in Psychiatric Practice
Narrative Review

June 2, 2025

Idiopathic hypersomnia, characterized by excessive daytime sleepiness (EDS), has an estimated population prevalence up to 1.5%. Psychiatric medications may exacerbate EDS and, conversely, idiopathic hypersomnia treatments may exacerbate psychiatric…
, , , et al
JCP
Detecting Tardive Dyskinesia Using Video-based AI
Original Research

May 28, 2025

The algorithm reliably detected suspected tardive dyskinesia, reaching higher sensitivity and specificity than trained raters using the standard assessment.
, , , et al

Vol 86 • 2025 • Number 1

Read the Current Issue

Original Research

Psychological Support in Psychedelic Therapy

Original Research

Long-Term Safety and Efficacy of Esmethadone in MDD

Original Research

Suicidal Behaviors and Obstructive Sleep Apnea

Editorial

A Collaborative Endeavor

Brief Report

Sex Differences in PTSD among US Military Veterans

Clinical and Practical Psychopharmacology

Cannabis Use During Pregnancy and Neuropsychiatric Adverse Outcomes in Children and Young Adults
View current Issue

Explore Special Sections

View all topics
Focus on Psychosis Focus on Geriatric Psychiatry Focus on Women’s Mental Health Focus on Suicide Early Career Psychiatrists Focus on Psychotherapy

Original Research

JCP
Outpatient Ketamine Prescribing Practices in Psychiatry in the US: A Nationwide Survey Study
Original Research

May 26, 2025

There is significant variability in ketamine treatment in the community including indications, treatment duration, formulation, and setting of use. Increased oversight and specific practice guidelines are needed to ensure…
, ,
JCP
Prediction Of Adolescent Suicidal Events By Residual Depressive Symptoms
Original Research

May 21, 2025

Sleep disturbance and suicidal ideation were the strongest predictors of hospitalization, and, together with anhedonia, they consistently predicted suicidal events during follow-up.
, , , et al
JCP
Postpartum Distress in Women With and Without ADHD
Original Research

May 19, 2025

Women with ADHD were 1.14 times more likely to be diagnosed with mood disorder at 6 weeks postpartum and 1.21-1.24 times more likely to be diagnosed with a mood,…
, ,

Review Articles

JCP
Treating PTSD in Military Populations
Meta-Analysis

March 24, 2025

Integrating psychotherapies and pharmacotherapies may address multiple dimensions of PTSD more effectively than monotherapies.
, , , et al
JCP
Changes in Cognition in Patients With Schizophrenia
Meta-Analysis

September 25, 2024

Only marginal improvements in cognition were seen over time; the greatest were achieved for patients with an illness duration shorter than 10 years.
, , , et al
JCP
Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia
Review Article

August 21, 2024

Patients with schizophrenia and cognitive impairment had a 100% increase in relapse-related hospitalizations and ER visits versus patients with no (or only mild) cognitive impairment.
, , , et al
JCP
Cognitive Effects of ECT in Schizophrenia: A Review
Review Article

June 5, 2024

ECT was not associated with any significant cognitive deficits in people with treatment-resistant schizophrenia across global cognition, attention, language, visuospatial function, and executive function domains. The majority of studies…
,
JCP
Interpersonal Psychotherapy for PTSD: A Critical Review
Review Article

May 29, 2024

This critical review will give clinicians confidence in considering IPT as an alternative to exposure treatments for posttraumatic stress disorder.
JCP
Omega-3 PUFA Supplements for ADHD
Meta-Analysis

August 30, 2023

Although omega-3 polyunsaturated fatty acids (PUFAs) may not improve core symptoms of attention-deficit/hyperactivity disorder, longer-term PUFA supplementation may have potential benefits.
, , , et al

Read articles from ASCP Corner

ASCP Corner

Letters to the Editor

JCP
Erecting Barriers to Suicide by Removing Barriers to Science
Letter to the Editor

April 30, 2025

The authors comment on the implications of a recent NSF communication warning researchers about the use of certain terms in grant proposals and publications made possible with government funding.
, , , et al
JCP
The Need for Clinical Guidance on Ketamine/Esketamine Use in Clinical Settings
Letter to the Editor

February 5, 2025

The authors comment on a recent study by Santucci et al.
,
JCP
Opioid Use Disorder in Sexually and Gender Diverse Populations: Can We Do Better?
Letter to the Editor

February 3, 2025

The authors respond to a recent JCP article by McDowell and colleagues.
, ,
JCP
Mental Health Assessment and Psychosocial Intervention in Maternal-Fetal Interventions
Letter to the Editor

November 18, 2024

In discussing a recent JCP letter to the editor, Akerson et al recommend that centers for fetal diagnosis and treatment include a social worker who can provide psychosocial assessment,…
, , , et al
JCP
Clarification Regarding the Psychiatrist’s Role—Reply to Akerson et al
Letter to the Editor

November 18, 2024

The authors respond to a letter by Akerson et al.
, , , et al
JCP
Detecting Misuse of Prescription Opioids
Letter to the Editor

October 21, 2024

The authors discuss the difficulty in screening for opioid misuse and the need for clinicians to gain confidence in initiating difficult discussions with patients on long-term opioid treatment.
, ,

Commentaries

JCP
Lower Risk of Cardiovascular Disorders in Antidepressant-Treated Women Veterans: Encouraging Findings but Concerns Remain
Commentary

May 7, 2025

Comments on a study by Sumner et al that followed 609,546 women veterans for a mean of 8.8 years to look at associations of antidepressants with incident CVD.
JCP
Benefits and Risks of New Tests for Alzheimer’s Disease
Commentary

April 14, 2025

The authors discuss the limitations and the potential value of blood-based biomarker testing in the detection and diagnosis of Alzheimer’s disease.
,
JCP
Investigation of Appetite Hormones Illustrates Current Limitations of Psychiatric Diagnosis
Commentary

April 9, 2025

Commenting on an article by Hsu and colleagues, Dr Mischoulon discusses the current state and future potential of biomarkers in the understanding and treatment of mood disorders.
JCP
Eating Disorders Among Transgender and Gender Diverse People: Qualitative Analysis of Reddit Threads
Commentary

March 10, 2025

This subreddit analysis characterizes the body dissatisfaction and desire to eliminate gendered physical characteristics that transgender and gender diverse (TGD) people with eating disorders experience. Many on the subreddit…
, ,
JCP
A New Tool to Refine Lithium Therapy: Simple Formula for a Complex Problem
Commentary

March 3, 2025

The authors consider potential benefits and limitations of a new equation for estimating 12-hour serum lithium levels.
, ,
JCP
Back to the Office: The Room Where It Happens?
Commentary

March 3, 2025

The authors discuss in-person versus remote delivery of psychotherapy and present the findings of a survey characterizing current practice.
, , , et al

More JCP Articles

JCP
Delirium as a Precursor to Dementia in Type 2 DM Patients
Original Research

May 19, 2025

Type 2 diabetes mellitus patients with delirium had a dementia incidence of 42.75%, compared to 22.66% in those without delirium, with a clear dose-response relationship of higher dementia risk…
, , , et al
JCP
Autism Spectrum Disorder, 2: Imprecision of the Numerical Value of Risk When Examining Predictors of Risk in Regression
Clinical and Practical Psychopharmacology

May 14, 2025

The article examines how different procedures and approaches in analysis of the same data result in different odds ratio values. Also explained is how to evaluate a patient’s risk…
JCP
Impact of PTSD Treatment Type on Engagement
Original Research

May 14, 2025

Veterans in PTSD specialty clinics may be more likely to attend a greater number of sessions for EBPs, relative to other evidence-informed treatments.
, , , et al
JCP
PTSD vs Other Conditions After Trauma and Life Stress Exposure
Original Research

May 12, 2025

In the longest study to date co-examining the environmental etiology of PTSD and MDD, trauma and life stress contributed to both conditions.
, , , et al
JCP
Intranasal Oxytocin and Alcohol Behavioral Couple Therapy
Original Research

May 12, 2025

Participants were romantic couples (n=49 oxytocin, n=47 placebo) consisting of a patient with AUD and their partner. Oxytocin was safe and tolerable but did not provide additional benefit beyond…
, , , et al
JCP
Preference for Lisdexamfetamine vs CBT for Binge-Eating Disorder
Original Research

May 7, 2025

CBT and pharmacotherapy with lisdexamfetamine resulted in significant improvements in binge-eating disorder. Participants’ preferences for treatments were not associated with sociodemographic or clinical characteristics and did not moderate treatment…
, , , et al
JCP
Developing a Treatment-Resistant Depression Consultation Program, Part II: Assessment
Consensus Statement

May 7, 2025

Consensus recommendations about the goals of a consultation for treatment-resistant depression include establishing the primary diagnosis and comorbidities, clarifying symptoms, identifying goals, documenting treatment history, identifying treatment barriers, and…
, , , et al
JCP
Antidepressants and Incident Cardiovascular Disease in Women Veterans
Original Research

May 7, 2025

SSRIs, SNRIs, and other antidepressants were each associated with lower incidence of cardiovascular disease and stroke in this sample of women Veterans.
, , , et al
JCP
Vortioxetine for Cognitive Impairment in MDD Post-COVID
Original Research

May 5, 2025

Measures of cognitive function and depressive symptoms improved to a greater extent with vortioxetine than with escitalopram or sertraline in post-COVID syndrome participants with MDD.
, , , et al
JCP
Increased Risk of Suicide Attempt in Patients With Atopic Dermatitis
Original Research

May 5, 2025

People with atopic dermatitis had an elevated risk of suicide attempts, with an adjusted hazard ratio of 3.44.
, , , et al
JCP
Clozapine Monitoring in the Post-REMS World: Some Guidance for Clinicians
ASCP Corner

May 5, 2025

While the abolition of REMS for clozapine expands access, the change could create confusion. Among the most relevant examples are mismatches between FDA recommendations for lifetime monitoring and the…
,
JCP
Correction

May 2, 2025

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe